392 related articles for article (PubMed ID: 6205468)
1. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB.
Sheehy MJ; Quintieri FB; Yang SY; Alosco SM; Matsui Y; Yunis EJ; Gabbay KH
Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
3. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
4. A minor subset of HLA-DR3 haplotypes is preferentially increased in type 1 (insulin-dependent) diabetes.
Sheehy MJ; Rowe JR; Fuller TC; Yunis EJ; Gabbay KH
Diabetologia; 1985 Dec; 28(12):891-4. PubMed ID: 3937758
[TBL] [Abstract][Full Text] [Related]
5. Age--related heterogeneity of insulin-dependent diabetes mellitus.
Deschamps I; Lestradet H; Goderel I; Marcelli-Barge A; Schmid M; Hors J
Diabete Metab; 1983 Dec; 9(4):259-63. PubMed ID: 6607851
[TBL] [Abstract][Full Text] [Related]
6. [The HLA system and insulin-dependent diabetes mellitus. A review and personal studies].
Citro M; Gadaleta G; Gamba Ansaldi S; Molinatti M; Salvetti E; Bruni B
Ann Osp Maria Vittoria Torino; 1983; 26(1-6):108-42. PubMed ID: 6388459
[TBL] [Abstract][Full Text] [Related]
7. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
8. The characteristics of the HLA antigens determined by cellular techniques.
Buc M; Stefanovic J
Allerg Immunol (Leipz); 1986; 32(1):19-25. PubMed ID: 2424294
[TBL] [Abstract][Full Text] [Related]
9. Type one (insulin dependent) diabetes mellitus in children--H.L.A. DR antigen association.
Dundon S; Finch A
Ir Med J; 1983 May; 76(5):255-8. PubMed ID: 6347962
[No Abstract] [Full Text] [Related]
10. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.
Matsui Y; Alosco SM; Awdeh Z; Duquesnoy RJ; Page PL; Hartzman RJ; Alper CA; Yunis EJ
Immunogenetics; 1984; 20(6):623-31. PubMed ID: 6239824
[TBL] [Abstract][Full Text] [Related]
11. [HLA association of insulin-dependent diabetes mellitus type I (author's transl)].
Bertrams J; Sodomann P; Gries FA; Sachsse B; Jahnke K
Dtsch Med Wochenschr; 1981 Jul; 106(29-30):927-32. PubMed ID: 7021118
[TBL] [Abstract][Full Text] [Related]
12. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
[TBL] [Abstract][Full Text] [Related]
13. Insulin-specific human T cells. Epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes-associated haplotype.
Miller GG; Pollack MS; Nell LJ; Thomas JW
J Immunol; 1987 Dec; 139(11):3622-9. PubMed ID: 2445817
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens.
Biddison WE; Shaw S
Diagn Immunol; 1983; 1(3):112-5. PubMed ID: 6209053
[TBL] [Abstract][Full Text] [Related]
15. A new homozygous typing cell with HLA-D"H" (DB6) specificity. Evidence that the DN-1 monoclonal antibody 9w925 is specific for the HLA-D"H" determinant.
Jakobsen BK; Platz P; Ryder LP; Svejgaard A
Tissue Antigens; 1986 May; 27(5):285-90. PubMed ID: 2425455
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M
Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528
[TBL] [Abstract][Full Text] [Related]
17. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals.
Naquet P; Ellis J; Tibensky D; Kenshole A; Singh B; Hodges R; Delovitch TL
J Immunol; 1988 Apr; 140(8):2569-78. PubMed ID: 2451692
[TBL] [Abstract][Full Text] [Related]
18. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
Gonwa TA; Picker LJ; Raff HV; Goyert SM; Silver J; Stobo JD
J Immunol; 1983 Feb; 130(2):706-11. PubMed ID: 6184401
[TBL] [Abstract][Full Text] [Related]
19. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
20. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
